RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Crosstalk between Sirtuins and Nrf2: SIRT1 activators as emerging treatment for diabetic neuropathy.

Crosstalk between Sirtuins and Nrf2: SIRT1 activators as emerging treatment for diabetic neuropathy.

Add to Collection
2022 Oct Others Fist_Author_Year_PM

Full Author : ['Patel, Shivangi', 'Khan, Hasnat', 'Majumdar, Anuradha']
Journal Title : Metabolic brain disease
Chapter : Section3
Journal Year : 2022
Cited by : Not Available

About 50% of the diabetic patients worldwide suffer from Diabetic peripheral neuropathy (DPN) which is characterized by chronic pain and loss of sensation, frequent foot ulcerations, and risk for amputation. Numerous factors like hyperglycemia, oxidative .....

Keywords : ["emerge treatment", "diabetic neuropathy", "sirtuin", "crosstalk", "activator"]